New MS drug shows promise in Long-Term trial

NCT ID NCT04130997

Ongoing Disease control Sponsor: TG Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Oct 31, 2025 · Last updated May 15, 2026 · Updated 26 times

Summary

This study looks at the long-term safety and effectiveness of ublituximab, a drug for relapsing multiple sclerosis (RMS). About 1,100 people who completed earlier studies will continue treatment. The main goal is to see how well the drug reduces relapse rates over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

TG Investigational Trial Site

Zagreb, 10000, Croatia
TG Therapeutics Investigational Trial Site

Pasadena, California, 91105, United States
TG Therapeutics Investigational Trial Site

Denver, Colorado, 80045, United States
TG Therapeutics Investigational Trial Site

Miami, Florida, 33136, United States
TG Therapeutics Investigational Trial Site

Tampa, Florida, 33612, United States
TG Therapeutics Investigational Trial Site

Northbrook, Illinois, 60062, United States
TG Therapeutics Investigational Trial Site

Kansas City, Kansas, 66160, United States
TG Therapeutics Investigational Trial Site

Detroit, Michigan, 48201, United States
TG Therapeutics Investigational Trial Site

Las Vegas, Nevada, 89106, United States
TG Therapeutics Investigational Trial Site

Teaneck, New Jersey, 07666, United States
TG Therapeutics Investigational Trial Site

Albuquerque, New Mexico, 87131, United States
TG Therapeutics Investigational Trial Site

Amherst, New York, 14266, United States
TG Therapeutics Investigational Trial Site

Columbus, Ohio, 43214, United States
TG Therapeutics Investigational Trial Site

Westerville, Ohio, 43081, United States
TG Therapeutics Investigational Trial Site

Knoxville, Tennessee, 37922, United States
TG Therapeutics Investigational Trial Site

Dallas, Texas, 75246, United States
TG Therapeutics Investigational Trial Site

Frisco, Texas, 75034, United States
TG Therapeutics Investigational Trial Site

Round Rock, Texas, 78681, United States
TG Therapeutics Investigational Trial Site

San Antonio, Texas, 78258, United States
TG Therapeutics Investigational Trial Site

Seattle, Washington, 98109, United States
TG Therapeutics Investigational Trial Site

Grodno, 230017, Belarus
TG Therapeutics Investigational Trial Site

Grodno, 320017, Belarus
TG Therapeutics Investigational Trial Site

Minsk, 220114, Belarus
TG Therapeutics Investigational Trial Site

Minsk, 220116, Belarus
TG Therapeutics Investigational Trial Site

Minsk, 220226, Belarus
TG Therapeutics Investigational Trial Site

Osijek, 31000, Croatia
TG Therapeutics Investigational Trial Site

Varaždin, 42000, Croatia
TG Therapeutics Investigational Trial Site

Tbilisi, 00112, Georgia
TG Therapeutics Investigational Trial Site

Tbilisi, 00114, Georgia
TG Therapeutics Investigational Trial Site

Tbilisi, 00159, Georgia
TG Therapeutics Investigational Trial Site

Tbilisi, 00160, Georgia
TG Therapeutics Investigational Trial Site

Tbilisi, 00172, Georgia
TG Therapeutics Investigational Trial Site

Tbilisi, 00179, Georgia
TG Therapeutics Investigational Trial Site

Katowice, 40-555, Poland
TG Therapeutics Investigational Trial Site

Katowice, 40-568, Poland
TG Therapeutics Investigational Trial Site

Katowice, 40-684, Poland
TG Therapeutics Investigational Trial Site

Krakow, 31-505, Poland
TG Therapeutics Investigational Trial Site

Lodz, 41-800, Poland
TG Therapeutics Investigational Trial Site

Olsztyn, 10-561, Poland
TG Therapeutics Investigational Trial Site

Poznan, 61-583, Poland
TG Therapeutics Investigational Trial Site

Warsaw, 04-141, Poland
TG Therapeutics Investigational Trial Site

Zabrze, 04-749, Poland
TG Therapeutics Investigational Trial Site

Arkhangelsk, 163045, Russia
TG Therapeutics Investigational Trial Site

Barnaul, 656045, Russia
TG Therapeutics Investigational Trial Site

Bryansk, 241033, Russia
TG Therapeutics Investigational Trial Site

Chelyabinsk, 454021, Russia
TG Therapeutics Investigational Trial Site

Kemerovo, 650066, Russia
TG Therapeutics Investigational Trial Site

Krasnoyarsk, 660037, Russia
TG Therapeutics Investigational Trial Site

Kursk, 305007, Russia
TG Therapeutics Investigational Trial Site

Moscow, 125367, Russia
TG Therapeutics Investigational Trial Site

Moscow, 127015, Russia
TG Therapeutics Investigational Trial Site

Nizhny Novgorod, 603155, Russia
TG Therapeutics Investigational Trial Site

Novosibirsk, 630007, Russia
TG Therapeutics Investigational Trial Site

Novosibirsk, 630087, Russia
TG Therapeutics Investigational Trial Site

Pyatigorsk, 357538, Russia
TG Therapeutics Investigational Trial Site

Saint Petersburg, 197002, Russia
TG Therapeutics Investigational Trial Site

Saint Petersburg, 197110, Russia
TG Therapeutics Investigational Trial Site

Saint Petersburg, 197376, Russia
TG Therapeutics Investigational Trial Site

Saransk, 430032, Russia
TG Therapeutics Investigational Trial Site

Smolensk, 214018, Russia
TG Therapeutics Investigational Trial Site

Tomsk, 634050, Russia
TG Therapeutics Investigational Trial Site

Tyumen, 625000, Russia
TG Therapeutics Investigational Trial Site

Ufa, 450005, Russia
TG Therapeutics Investigational Trial Site

Yekaterinburg, 620102, Russia
TG Therapeutics Investigational Trial Site

Belgrade, 11000, Serbia
TG Therapeutics Investigational Trial Site

Kragujevac, 34000, Serbia
TG Therapeutics Investigational Trial Site

Cherkasy, 18009, Ukraine
TG Therapeutics Investigational Trial Site

Chernihiv, 14001, Ukraine
TG Therapeutics Investigational Trial Site

Chernihiv, 14029, Ukraine
TG Therapeutics Investigational Trial Site

Chernivtsi, 58002, Ukraine
TG Therapeutics Investigational Trial Site

Ivano-Frankivsk, 76008, Ukraine
TG Therapeutics Investigational Trial Site

Kharkiv, 61058, Ukraine
TG Therapeutics Investigational Trial Site

Kharkiv, 61103, Ukraine
TG Therapeutics Investigational Trial Site

Kharkiv, 61176, Ukraine
TG Therapeutics Investigational Trial Site

Kyiv, 03037, Ukraine
TG Therapeutics Investigational Trial Site

Kyiv, 03115, Ukraine
TG Therapeutics Investigational Trial Site

Lviv, 79000, Ukraine
TG Therapeutics Investigational Trial Site

Lviv, 79010, Ukraine
TG Therapeutics Investigational Trial Site

Odesa, 65009, Ukraine
TG Therapeutics Investigational Trial Site

Poltava, 36011, Ukraine
TG Therapeutics Investigational Trial Site

Ternopil, 46027, Ukraine
TG Therapeutics Investigational Trial Site

Uzhhorod, 88018, Ukraine
TG Therapeutics Investigational Trial Site

Vinnytsia, 21005, Ukraine
TG Therapeutics Investigational Trial Site

Zaporizhia, 69065, Ukraine
TG Therapeutics Investigational Trial Site

Zaporizhia, 96900, Ukraine
TG Therapeutics Investigational Trial Site

Zhytomyr, 10002, Ukraine

Conditions

Explore the condition pages connected to this study.

RELAPSING MULTIPLE SCLEROSIS (RMS)